HQL - Tekla Life Sciences Investors

NYSE - Nasdaq Real Time Price. Currency in USD
16.92
+0.16 (+0.98%)
As of 12:01PM EDT. Market open.
Stock chart is not supported by your current browser
Previous Close16.76
Open16.80
Bid16.90 x 900
Ask16.95 x 1000
Day's Range16.80 - 16.96
52 Week Range13.95 - 20.68
Volume19,926
Avg. Volume89,708
Market Cap372.489M
Beta (3Y Monthly)1.50
PE Ratio (TTM)13.23
EPS (TTM)1.28
Earnings DateN/A
Forward Dividend & Yield1.32 (7.87%)
Ex-Dividend Date2018-08-27
1y Target EstN/A
Trade prices are not sourced from all markets
  • Business Wire5 days ago

    Tekla Life Sciences Investors Announce Renewal of Share Repurchase Program

    Tekla Life Sciences Investors (the “Fund”) announced today that its Board of Trustees authorized a renewal of its share repurchase program. The current share repurchase program allows the Fund to purchase in the open market up to 12% of its outstanding common shares for a one-year period ending July 14, 2019. The renewal will allow the Fund to purchase in the open market up to 12% of its outstanding common shares for a one year-period ending July 14, 2020.

  • Business Wire26 days ago

    Tekla Healthcare Opportunities Fund Paid Distribution

    On February 28, 2019, Tekla Healthcare Opportunities Fund paid a monthly distribution of $0.1125 per share. It is currently estimated that this distribution is derived from return of capital or other capital source.

  • Business Wire26 days ago

    Tekla World Healthcare Fund Paid Distribution

    It is currently estimated that this distribution is derived from return of capital or other capital source. The aggregate of the net unrealized depreciation of portfolio securities and net realized losses on sale of securities is -$120,256,116, of which $97,656,099 represents net unrealized depreciation of portfolio securities. The following table sets forth the estimated amounts of the current distribution, paid on February 28, 2019, and the cumulative distributions paid this fiscal year-to-date from the following sources: net investment income, net realized short-term capital gains, net realized long-term capital gains, and return of capital or other capital source.

  • Business Wirelast month

    Tekla Life Sciences Investors Declares Stock Distribution

    On February 15, 2019, Tekla Life Sciences Investors declared a stock distribution of $0.33 per share. The record date for the stock distribution is February 28, 2019 and the payable date is March 29, 2019. This stock distribution will automatically be paid in newly issued shares of the Fund unless otherwise instructed by the shareholder.

  • MoneyShow2 months ago

    Top Picks 2019- Tekla Life Sciences Investors HQL

    For more conservative investors, my top income pick for the coming year is Tekla Life Sciences Investors (HQL), a closed-end fund, explains Nate Pile, editor of Nate's Notes and a specialist in healthcare and biotechnology stocks.

  • Business Wire3 months ago

    Tekla Healthcare Investors Paid Distribution

    On December 31, 2018, Tekla Healthcare Investors paid a distribution of $0.51 per share. It is currently estimated that this distribution is derived from net realized short-term capital gains and return of capital or other capital source.

  • Business Wire3 months ago

    Tekla Life Sciences Investors Paid Distribution

    On December 31, 2018, Tekla Life Sciences Investors paid a distribution of $0.42 per share. It is currently estimated that this distribution is derived from net realized short-term capital gains and return of capital or other capital source.